Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Aurobindo Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524804NSE Symbol: AUROPHARMAP/E(TTM):33.51
ISIN Demat:INE406A01037Div & Yield %:0.67EPS(TTM):33.56
Book Value(Rs):318.5455537Market Cap ( Cr.):65903.45Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 12792.2811287.1415823.6813370.7712257.8910303.15
Excise Duty0.000.000.000.000.0033.25
Net Sales12792.2811287.1415823.6813370.7712257.8910269.90
Other Income 433.76670.99589.86388.79199.2280.65
Stock Adjustments 466.00-45.51-2.99238.67289.80334.18
Total Income13692.0411912.6216410.5513998.2312746.9110684.73
EXPENDITURE :      
Raw Materials 7336.925800.747241.836819.856469.554896.99
Power & Fuel Cost613.92477.99512.34526.31505.96433.02
Employee Cost 1641.881600.041735.421577.141362.771131.64
Other Manufacturing Expenses 650.91705.68925.86814.44795.13630.28
Selling and Administration Expenses 1089.331009.361069.84938.36786.90724.40
Miscellaneous Expenses 194.40249.13215.57235.47218.09117.74
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure11527.369842.9411700.8610911.5710138.407934.07
Operating Profit2164.682069.684709.693086.662608.512750.66
Interest 114.9816.9428.68243.28230.8652.89
Gross Profit2049.702052.744681.012843.382377.652697.77
Depreciation435.35415.26488.00473.33413.03354.83
Profit Before Tax1614.351637.484193.012370.051964.622342.94
Tax407.02379.701043.34492.28378.56462.02
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-23.08-196.9336.760.8956.3368.15
Reported Net Profit1230.411454.713112.911876.881529.731812.77
Extraordinary Items 9.98-81.27-0.13-1.90-8.01-0.05
Adjusted Net Profit1220.431535.983113.041878.781537.741812.82
Adjst. below Net Profit 5.871.69-6.42-44.880.00-44.73
P & L Balance brought forward15864.1414671.4111799.3010143.088790.747242.41
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 439.45263.67234.38175.78160.34219.71
P & L Balance carried down16660.9715864.1414671.4111799.3010160.138790.74
Dividend0.000.000.000.00146.480.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %750.00900.00400.00300.00250.00250.00
Earnings Per Share-Unit Curr21.0024.8353.1332.0326.1130.94
Earnings Per Share(Adj)-Unit Curr21.0024.8353.1332.0326.1130.94
Book Value-Unit Curr305.75292.15271.80222.78193.73170.38